Actively Recruiting
Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 4
Led by KU Leuven · Updated on 2024-09-19
120
Participants Needed
2
Research Sites
87 weeks
Total Duration
On this page
Sponsors
K
KU Leuven
Lead Sponsor
U
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsor
AI-Summary
What this Trial Is About
Research investigating measurement properties for evaluating the decongestive treatment effect on different edema characteristics (e.g. water volume, hardness of the skin, water content,..) at the level of the lower limbs is missing. Information about the clinical relevant change criteria after treatment for nearly all these edema characteristics, is not present and requires investigation. To assess the merits of each treatment in a reproducible manner, a reliable way of measuring limb volume and other edema characteristics must be established, as the evaluation of treatment effects without appropriate tools might lead to biased treatment effects. First of all, in clinical practice, it is of utmost importance to know which edema characteristics need to be evaluated in order to assess the clinical evolution of a patient with lymphedema during and after treatment. Secondly, in order to draw proper conclusions about the treatment effect, it is necessary that to know from which criterion (or cut-off value) one can speak of a real clinical change for a certain lymphedema characteristic. Given that the edema characteristics that are most responsive to treatment and their corresponding criteria for clinically significant and relevant changes at the lower limbs have never been investigated before, the need for this research is high. Therefore, the research questions in this study are: Which measurement tool(s) are able to detect clinically relevant changes in the lymphedema characteristics after the intensive treatment and during the maintenance treatment? When can a clinician speak of a clinically relevant change?
CONDITIONS
Official Title
Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 4
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosis of unilateral or bilateral primary or secondary lower limb lymphedema
- No active metastases
- If cancer-related lymphedema, surgery, radiotherapy, or chemotherapy occurred at least 3 months ago
- Objective diagnosis of lymphedema by at least one of: 5% or greater volume difference, 2 minor or 1 major lymphoscintigraphy criteria, or presence of ICG dermal backflow
- Able to read, understand, and speak Dutch
- Planned to start intensive decongestive lymphatic therapy for intensive treatment group
- For maintenance treatment group: completed intensive treatment phase at least 3 months ago and currently receiving maintenance therapy
You will not qualify if you...
- Pregnant participants
- Chronic venous insufficiency classified as C4, C5, or C6
- Deep venous thrombosis or post-thrombotic syndrome
- Skin infections or wounds on lower limbs at the time of inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospitals of Leuven
Leuven, Belgium, 3000
Actively Recruiting
2
Nij Smellinghe Hospital
Drachten, Netherlands, 9202
Not Yet Recruiting
Research Team
T
Tessa De Vrieze, Dr.
CONTACT
N
Nele Devoogdt, Prof. Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here